|
|
Volumn 17, Issue 9, 1999, Pages 930-931
|
|
Cardiovascular disease drug discovery
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
ARGATROBAN;
CARDIOVASCULAR AGENT;
LANOTEPLASE;
MONOCLONAL ANTIBODY;
PLASMINOGEN ACTIVATOR;
STREPTOKINASE;
BIOTECHNOLOGY;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
DIAGNOSTIC APPROACH ROUTE;
DRUG RESEARCH;
DRUG SCREENING;
GENE THERAPY;
HEALTH CARE COST;
HUMAN;
PHASE 2 CLINICAL TRIAL;
PREVALENCE;
PRIORITY JOURNAL;
SHORT SURVEY;
BIOTECHNOLOGY;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS;
DELIVERY OF HEALTH CARE;
DRUG DESIGN;
DRUG INDUSTRY;
DRUGS, INVESTIGATIONAL;
HUMANS;
|
|
EID: 0032858738
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: 10.1038/12935 Document Type: Short Survey |
|
Times cited : (7)
|
|
References (7)
|
